Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

A Review of Various Antioxidant Compounds and their Potential Utility as Complementary Therapy in Multiple Sclerosis.

Miller ED, Dziedzic A, Saluk-Bijak J, Bijak M.

Nutrients. 2019 Jul 5;11(7). pii: E1528. doi: 10.3390/nu11071528. Review.

2.

Increased level of fibrinogen chains in the proteome of blood platelets in secondary progressive multiple sclerosis patients.

Bijak M, Olejnik A, Rokita B, Morel A, Dziedzic A, Miller E, Saluk-Bijak J.

J Cell Mol Med. 2019 May;23(5):3476-3482. doi: 10.1111/jcmm.14244. Epub 2019 Mar 5.

3.

Pro-Thrombotic Activity of Blood Platelets in Multiple Sclerosis.

Saluk-Bijak J, Dziedzic A, Bijak M.

Cells. 2019 Feb 1;8(2). pii: E110. doi: 10.3390/cells8020110. Review.

4.

Interactions between platelets and leukocytes in pathogenesis of multiple sclerosis.

Dziedzic A, Bijak M.

Adv Clin Exp Med. 2019 Feb;28(2):277-285. doi: 10.17219/acem/83588. Review.

5.

Inhibitory Effect of Flavonolignans on the P2Y12 Pathway in Blood Platelets.

Bijak M, Szelenberger R, Dziedzic A, Saluk-Bijak J.

Molecules. 2018 Feb 10;23(2). pii: E374. doi: 10.3390/molecules23020374.

6.

Flavonolignans Inhibit IL1-β-Induced Cross-Talk between Blood Platelets and Leukocytes.

Bijak M, Dziedzic A, Synowiec E, Sliwinski T, Saluk-Bijak J.

Nutrients. 2017 Sep 15;9(9). pii: E1022. doi: 10.3390/nu9091022.

7.

Flavonolignans reduce the response of blood platelet to collagen.

Bijak M, Dziedzic A, Saluk-Bijak J.

Int J Biol Macromol. 2018 Jan;106:878-884. doi: 10.1016/j.ijbiomac.2017.08.091. Epub 2017 Aug 23.

PMID:
28842200
8.

[Inflammatory processes in the pathogenesis of acute coronary syndromes].

Lach D, Cichon N, Dziedzic A, Bijak M, Saluk J.

Pol Merkur Lekarski. 2017 May 23;42(251):183-186. Review. Polish.

PMID:
28557963
9.

[The inflammatory processes in atherogenesis].

Cichoń N, Lach D, Dziedzic A, Bijak M, Saluk J.

Pol Merkur Lekarski. 2017 Mar 21;42(249):125-128. Review. Polish.

PMID:
28333905

Supplemental Content

Loading ...
Support Center